Join
Live feed
·
INSIDERFilingvia Quantisnow
BioAge Labs Inc. logo

Director Healy James converted options into 1,638,236 shares and bought $11,999,970 worth of shares (666,665 units at $18.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BIOA· BioAge Labs Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOA (BioAge Labs Inc.) and more on Quantisnow.